ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
190 hedge funds and large institutions have $1.92B invested in ChemoCentryx, Inc. in 2021 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 25 closing their positions.
204% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 25
153% more capital invested
Capital invested by funds: $761M → $1.92B (+$1.16B)
120% more call options, than puts
Call options by funds: $70M | Put options by funds: $31.8M
36% more funds holding
Funds holding: 140 → 190 (+50)
12% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$56.4M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$46.7M |
| 3 |
Millennium Management
New York
|
+$33.2M |
| 4 |
PA
Perceptive Advisors
New York
|
+$30.4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$29.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$67M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$27.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$14.7M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$9.95M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$9.29M |
CCXI Hedge Fund Activity: Q4 2021 in Review
190 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2021, worth a combined $1.92B — up 153% from $761M a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new CCXI positions and 25 closed out — a net gain of 51 holders — while 46 added to existing stakes and 52 trimmed.
The largest buyer was Pictet Asset Management (Switzerland), opening a new position worth an estimated $56.4M. The largest seller was State Street, cutting an estimated $67M.
- 190 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2021, up from 140 in Q3 2021.
- Funds reported $1.92B of ChemoCentryx, Inc. stock for Q4 2021, up 153% quarter-over-quarter.
- 76 funds opened new ChemoCentryx, Inc. positions in Q4 2021 and 25 closed out, a net change of +51 holders.
- The largest ChemoCentryx, Inc. buyer in Q4 2021 was Pictet Asset Management (Switzerland), an estimated $56.4M added.
- The largest ChemoCentryx, Inc. seller in Q4 2021 was State Street, an estimated $67M sold.
Based on aggregated 13F filings for Q4 2021.